Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Non-structural protein 5A (NS5A) is a multifunctional, zinc-binding, proline-rich hydrophilic phosphoprotein that plays a central role in the life cycle of the Hepatitis C virus (HCV), particularly in viral RNA replication and assembly. It interacts with other viral and host cellular proteins, exists predominantly as a dimer, and associates with intracellular membranes via an N-terminal amphipathic α-helix. NS5A comprises three domains, with domains II & III being largely natively unfolded, allowing conformational flexibility for diverse interactions. NS5A exists in two major phosphorylated forms, p56 and p58, with the phosphorylation status influencing RNA replication efficiency and protein interaction. It modulates multiple cellular signaling pathways, antagonizes innate immune responses, and is a validated target for direct acting antivirals (DAAs) used in treating chronic hepatitis C infection.
Inhibition of NS5A function, disrupting RNA replication and virion assembly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-structural protein 5A (NS5A).